Versant Capital Management Inc Raises Position in Integer Holdings Co. (NYSE:ITGR)

Versant Capital Management Inc increased its holdings in Integer Holdings Co. (NYSE:ITGR) by 98.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 369 shares of the medical equipment provider’s stock after purchasing an additional 183 shares during the period. Versant Capital Management Inc’s holdings in Integer were worth $49,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Earnest Partners LLC boosted its holdings in shares of Integer by 3.2% in the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after purchasing an additional 37,340 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Integer by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock worth $99,408,000 after buying an additional 9,421 shares during the period. Loomis Sayles & Co. L P boosted its holdings in Integer by 3.0% in the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock valued at $69,943,000 after acquiring an additional 15,446 shares during the last quarter. Congress Asset Management Co. grew its position in Integer by 3.9% during the third quarter. Congress Asset Management Co. now owns 488,785 shares of the medical equipment provider’s stock valued at $63,542,000 after acquiring an additional 18,303 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in Integer by 1.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 404,029 shares of the medical equipment provider’s stock worth $52,524,000 after acquiring an additional 4,946 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently weighed in on ITGR shares. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. KeyCorp lifted their price target on shares of Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research report on Tuesday, October 15th. Benchmark increased their price objective on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. Piper Sandler restated an “overweight” rating and set a $140.00 target price (up previously from $125.00) on shares of Integer in a report on Friday, October 25th. Finally, Truist Financial upped their price target on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, Integer has a consensus rating of “Moderate Buy” and an average target price of $145.44.

Integer Stock Down 0.4 %

Shares of Integer stock opened at $133.41 on Tuesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. Integer Holdings Co. has a 1-year low of $94.56 and a 1-year high of $142.76. The business has a 50-day moving average of $135.34 and a 200-day moving average of $127.40. The company has a market capitalization of $4.47 billion, a PE ratio of 41.18, a P/E/G ratio of 1.99 and a beta of 1.12.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.07. The company had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. Integer’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.27 EPS. As a group, equities analysts forecast that Integer Holdings Co. will post 5.33 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.